| Outgoing Relation(s) |
| hormone antagonist (CHEBI:49020) is a antagonist (CHEBI:48706) |
| hormone antagonist (CHEBI:49020) is a hormone receptor modulator (CHEBI:51061) |
| Incoming Relation(s) |
| 6-propyl-2-thiouracil (CHEBI:8502) has role hormone antagonist (CHEBI:49020) |
| abarelix (CHEBI:337298) has role hormone antagonist (CHEBI:49020) |
| baicalein (CHEBI:2979) has role hormone antagonist (CHEBI:49020) |
| baicalein(1−) (CHEBI:78324) has role hormone antagonist (CHEBI:49020) |
| bromocriptine (CHEBI:3181) has role hormone antagonist (CHEBI:49020) |
| mifepristone (CHEBI:50692) has role hormone antagonist (CHEBI:49020) |
| androgen antagonist (CHEBI:35497) is a hormone antagonist (CHEBI:49020) |
| angiotensin receptor antagonist (CHEBI:61016) is a hormone antagonist (CHEBI:49020) |
| antimineralocorticoid (CHEBI:50843) is a hormone antagonist (CHEBI:49020) |
| antiparathyroid drug (CHEBI:50827) is a hormone antagonist (CHEBI:49020) |
| antithyroid drug (CHEBI:50671) is a hormone antagonist (CHEBI:49020) |
| cholecystokinin antagonist (CHEBI:73296) is a hormone antagonist (CHEBI:49020) |
| corticotropin-releasing factor receptor antagonist (CHEBI:76977) is a hormone antagonist (CHEBI:49020) |
| endothelin receptor antagonist (CHEBI:51451) is a hormone antagonist (CHEBI:49020) |
| estrogen antagonist (CHEBI:50837) is a hormone antagonist (CHEBI:49020) |
| glucagon receptor antagonist (CHEBI:60649) is a hormone antagonist (CHEBI:49020) |
| GnRH antagonist (CHEBI:59229) is a hormone antagonist (CHEBI:49020) |
| leukotriene antagonist (CHEBI:49159) is a hormone antagonist (CHEBI:49020) |
| prostaglandin antagonist (CHEBI:49023) is a hormone antagonist (CHEBI:49020) |
| vasopressin receptor antagonist (CHEBI:59680) is a hormone antagonist (CHEBI:49020) |
